BioSpace News Archive

Business

AdaptHealth Corp. Announces Third Quarter 2022 Results and Updates 2022 Outlook

AdaptHealth Corp. announced today financial results for the third quarter ended September 30, 2022.

November 8, 2022
·
17 min read
Business

IMV Inc. to Announce Third Quarter 2022 Results and Host a Conference Call and Webcast on November 11, 2022

IMV Inc. today announced that it will hold a conference call and webcast on Friday, November 11, 2022, at 8:00 a.m. ET to discuss the company’s 2022 third quarter financial and operational results.

November 8, 2022
·
4 min read
BioMidwest

Cardio Diagnostics Holdings Inc Sponsors Becker’s Hospital Review 11th Annual Meeting - The CEO + CFO Roundtable

Cardio Diagnostics Holdings Inc (NASDAQ: CDIO) today announced that it is sponsoring Becker’s Hospital Review 11th Annual Meeting, “The CEO + CFO Roundtable.”

November 8, 2022
·
7 min read
Business

Fulcrum Therapeutics Announces Recent Business Highlights and Third Quarter 2022 Financial Results

Fulcrum Therapeutics, Inc.® (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically defined rare diseases, today reported financial results for the third quarter of 2022.

November 8, 2022
·
8 min read
Pharm Country

Arbutus to Present at Jefferies London Healthcare Conference

Arbutus Biopharma Corporation today announced that William Collier, Arbutus’ President and Chief Executive Officer, will present at the Jefferies London Healthcare Conference on Wednesday, November 16, 2022, at 11:30 am GMT / 6:30 am EDT.

November 8, 2022
·
1 min read
Business

Neuronetics Reports Third Quarter 2022 Financial and Operating Results

Neuronetics, Inc. today announced its financial and operating results for the third quarter of 2022.

November 8, 2022
·
15 min read
Business

Sensei Biotherapeutics Reports Third Quarter 2022 Financial Results and Recent Business Highlights

Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), an immuno-oncology company focused on the discovery and development of next generation therapeutics for cancer patients, today reported financial results for the third quarter ended September 30, 2022 and provided recent business updates.

November 8, 2022
·
9 min read
Business

Zai Lab Announces the Appointment of Dr. Peter Huang as Chief Scientific Officer

Zai Lab Limited today announced the appointment of Dr. Peter Huang as its Chief Scientific Officer (CSO), effective immediately.

November 8, 2022
·
5 min read
Business

Reneo Pharmaceuticals Reports Third Quarter 2022 Financial Results

Reneo Pharmaceuticals, Inc. today reported financial results for the quarter ended September 30, 2022.

November 8, 2022
·
10 min read
Genetown

Repligen Corporation to Present at Upcoming November 2022 Investor Conferences

Repligen Corporation, a life sciences company focused on bioprocessing technology leadership, announced that it will present at two upcoming investor conferences.

November 8, 2022
·
1 min read